Disruption of PML Nuclear Bodies Is Mediated by ORF61 SUMO-Interacting Motifs and Required for Varicella-Zoster Virus Pathogenesis in Skin
Promyelocytic leukemia protein (PML) has antiviral functions and many viruses encode gene products that disrupt PML nuclear bodies (PML NBs). However, evidence of the relevance of PML NB modification for viral pathogenesis is limited and little is known about viral gene functions required for PML NB disruption in infected cells in vivo. Varicella-zoster virus (VZV) is a human alphaherpesvirus that causes cutaneous lesions during primary and recurrent infection. Here we show that VZV disrupts PML NBs in infected cells in human skin xenografts in SCID mice and that the disruption is achieved by open reading frame 61 (ORF61) protein via its SUMO-interacting motifs (SIMs). Three conserved SIMs mediated ORF61 binding to SUMO1 and were required for ORF61 association with and disruption of PML NBs. Mutation of the ORF61 SIMs in the VZV genome showed that these motifs were necessary for PML NB dispersal in VZV-infected cells in vitro. In vivo, PML NBs were highly abundant, especially in basal layer cells of uninfected skin, whereas their frequency was significantly decreased in VZV-infected cells. In contrast, mutation of the ORF61 SIMs reduced ORF61 association with PML NBs, most PML NBs remained intact and importantly, viral replication in skin was severely impaired. The ORF61 SIM mutant virus failed to cause the typical VZV lesions that penetrate across the basement membrane into the dermis and viral spread in the epidermis was limited. These experiments indicate that VZV pathogenesis in skin depends upon the ORF61-mediated disruption of PML NBs and that the ORF61 SUMO-binding function is necessary for this effect. More broadly, our study elucidates the importance of PML NBs for the innate control of a viral pathogen during infection of differentiated cells within their tissue microenvironment in vivo and the requirement for a viral protein with SUMO-binding capacity to counteract this intrinsic barrier.
Vyšlo v časopise:
Disruption of PML Nuclear Bodies Is Mediated by ORF61 SUMO-Interacting Motifs and Required for Varicella-Zoster Virus Pathogenesis in Skin. PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002157
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002157
Souhrn
Promyelocytic leukemia protein (PML) has antiviral functions and many viruses encode gene products that disrupt PML nuclear bodies (PML NBs). However, evidence of the relevance of PML NB modification for viral pathogenesis is limited and little is known about viral gene functions required for PML NB disruption in infected cells in vivo. Varicella-zoster virus (VZV) is a human alphaherpesvirus that causes cutaneous lesions during primary and recurrent infection. Here we show that VZV disrupts PML NBs in infected cells in human skin xenografts in SCID mice and that the disruption is achieved by open reading frame 61 (ORF61) protein via its SUMO-interacting motifs (SIMs). Three conserved SIMs mediated ORF61 binding to SUMO1 and were required for ORF61 association with and disruption of PML NBs. Mutation of the ORF61 SIMs in the VZV genome showed that these motifs were necessary for PML NB dispersal in VZV-infected cells in vitro. In vivo, PML NBs were highly abundant, especially in basal layer cells of uninfected skin, whereas their frequency was significantly decreased in VZV-infected cells. In contrast, mutation of the ORF61 SIMs reduced ORF61 association with PML NBs, most PML NBs remained intact and importantly, viral replication in skin was severely impaired. The ORF61 SIM mutant virus failed to cause the typical VZV lesions that penetrate across the basement membrane into the dermis and viral spread in the epidermis was limited. These experiments indicate that VZV pathogenesis in skin depends upon the ORF61-mediated disruption of PML NBs and that the ORF61 SUMO-binding function is necessary for this effect. More broadly, our study elucidates the importance of PML NBs for the innate control of a viral pathogen during infection of differentiated cells within their tissue microenvironment in vivo and the requirement for a viral protein with SUMO-binding capacity to counteract this intrinsic barrier.
Zdroje
1. BernardiRPandolfiPP 2007 Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8 1006 1016
2. IshovAMSotnikovAGNegorevDVladimirovaOVNeffN 1999 PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147 221 234
3. AotoTSaitohNIchimuraTNiwaHNakaoM 2006 Nuclear and chromatin reorganization in the MHC-Oct3/4 locus at developmental phases of embryonic stem cell differentiation. Dev Biol 298 354 367
4. FlenghiLFagioliMTomassoniLPileriSGambacortaM 1995 Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia. Blood 85 1871 1880
5. ChoYLeeIMaulGGYuE 1998 A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues. Int J Mol Med 1 717 724
6. LavauCMarchioAFagioliMJansenJFaliniB 1995 The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene 11 871 876
7. EverettRDChelbi-AlixMK 2007 PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89 819 830
8. BonillaWVPinschewerDDKlenermanPRoussonVGaboliM 2002 Effects of promyelocytic leukemia protein on virus-host balance. J Virol 76 3810 3818
9. ReicheltMWangLSommerMPerrinoJNourAM 2011 Entrapment of viral capsids in nuclear PML cages is an intrinsic host defense against a neurotropic human herpesvirus. PLoS Pathog 7 e1001266
10. CohenJIStrausSEArvinAM 2007 Varicella-zoster virus replication, pathogenesis, and management. KnipeDMHowleyPMGriffinDELambRAMartinMARoizmanBStrausSELippincott WilliamsWilkinsPhiladelphiaPA Fields virology, 5th ed, eds Vol 2 2774 2806
11. EverettRDRechterSPapiorPTavalaiNStammingerT 2006 PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol 80 7995 8005
12. CheeAVLopezPPandolfiPPRoizmanB 2003 Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77 7101 7105
13. KyratsousCASilversteinSJ 2009 Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. J Virol 83 4262 4274
14. MaulGGEverettRD 1994 The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 75 1223 1233
15. Chelbi-AlixMKde TheH 1999 Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18 935 941
16. HagglundRVan SantCLopezPRoizmanB 2002 Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 99 631 636
17. BoutellCSadisSEverettRD 2002 Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76 841 850
18. ReicheltMBradyJArvinAM 2009 The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol 83 3904 3918
19. WaltersMSKyratsousCASilversteinSJ 2010 The RING Finger Domain of Varicella-Zoster Virus ORF61p has E3 Ubiquitin Ligase Activity that is Essential for Efficient Auto-Ubiquitination and Dispersion of Sp100 Containing Nuclear Bodies. J Virol 84 6861 6865
20. EverettRDBoutellCMcNairCGrantLOrrA 2010 Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins. J Virol 84 3476 3487
21. MoriuchiHMoriuchiMStrausSECohenJI 1993 Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA. J Virol 67 4290 4295
22. CohenJINguyenH 1998 Varicella-zoster virus ORF61 deletion mutants replicate in cell culture, but a mutant with stop codons in ORF61 reverts to wild-type virus. Virology 246 306 316
23. WangLSommerMRajamaniJArvinAM 2009 Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis. J Virol 83 7560 7572
24. ZhangZSelariuAWardenCHuangGHuangY 2010 Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin tropic factor. PloS Pathog 6 e1000971 doi:10.1371/journal.ppat.1000971
25. MoffatJFSteinMDKaneshimaHArvinAM 1995 Tropism of varicella- zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol 69 5236 5242
26. ZerboniLKuCCJonesCDZehnderJLArvinAM 2005 Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A 102 6490 6495
27. ArvinAM 2006 Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Herpes 13 75 80
28. MintyADumontXKaghadMCaputD 2000 Covalent modification of p73α by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem 275 36316 36323
29. HannichJTLewisAKroetzMBLiSJHeideH 2005 Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J Biol Chem 280 4102 4110
30. HeckerCMRabillerMHaglundKBayerPDikicI 2006 Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem 281 16117 16127
31. SongJZhangZHuWChenY 2005 Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J Biol Chem 280 40122 40129
32. ShenTHLinHKScaglioniPPYungTMPandolfiPP 2006 The mechanisms of PML-nuclear body formation. Mol Cell 24 331 339
33. LinDYHuangYSJengJCKuoHYChangCC 2006 Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell 24 341 354
34. TathamMHGeoffroyMCShenLPlechanovovaAHattersleyN 2008 RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol 10 538 546
35. ChoGLimYGoldenJA 2009 SUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activation. J Biol Chem 284 19592 19600
36. Marcos-VillarLLopitz-OtsoaFGallegoPMuñoz-FontelaCGonzález-SantamaríaJ 2009 Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J Virol 83 8849 8858
37. MoriuchiHMoriuchiMCohenJI 1994 The RING finger domain of the varicella-zoster virus open reading frame 61 protein is required for its transregulatory functions. Virology 205 238 246
38. JonesJOArvinAM 2006 Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 80 5113 5124
39. KuCCZerboniLItoHGrahamBSWallaceM 2004 Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med 200 917 925
40. SenNSommerMCheXWhiteKRuyechanWT 2010 Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J Virol 84 9240 9253
41. BulmerJNMorrisonLJohnsonPM 1988 Expression of the proliferation markers Ki67 and transferrin receptor by human trophoblast populations. J Reprod Immunol. 14 291 302
42. SunHLeversonJDHunterT 2007 Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins. EMBO J 26 4102 4112
43. TanimuraSOhtsukaSMitsuiKShirouzuKYoshimuraA 1999 MDM2 interacts with MDMX through their RING finger domains. FEBS Lett 447 5 9
44. ParkinsonJEverettRD 2000 Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins. J Virol 74 10006 10017
45. RoizmanBKnipeDMWhitleyRJ 2007 Herpes simplex virus. KnipeDMHowleyPMGriffinDELambRAMartinMARoizmanBStrausSELippincott WilliamsWilkinsPhiladelphiaPA Fields virology, 5th ed, eds Vol 2 2503 2576
46. EverettRO′HarePO′RourkeDBarlowPOrrA 1995 Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures. J Virol 69 7339 7344
47. LinRNoyceRSCollinsSEEverettRDMossmanKL 2004 The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 78 1675 1684
48. DelboyMGSiekavizza-RoblesCRNicolaAV 2010 Herpes simplex virus tegument ICP0 is capsid associated, and its E3 ubiquitin ligase domain is important for incorporation into virions. J Virol 84 1637 1640
49. ChaudhuriVSommerMRajamaniJZerboniLArvinAM 2008 Functions of Varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J Virol 82 10231 10246
50. BerarducciBSommerMZerboniLRajamaniJArvinAM 2007 Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication. J Virol 81 10258 10267
51. NiizumaTZerboniLSommerMHItoHHinchliffeS 2003 Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J Virol 77 6062 6065
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 8
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
- Two Group A Streptococcal Peptide Pheromones Act through Opposing Rgg Regulators to Control Biofilm Development
- Differential Contribution of PB1-F2 to the Virulence of Highly Pathogenic H5N1 Influenza A Virus in Mammalian and Avian Species
- Recruitment of the Major Vault Protein by InlK: A Strategy to Avoid Autophagy